A service of StreetInsider.com
Ticker Symbol

Most Popular

AAPL 139.83
GOOG 813.99
MSFT 64.50
BAC 22.55
FB 139.98

Recently Added

RAS-A 0.00
PANW 110.57
STRL 9.41
LAYN 8.45
NOA 4.35

Gaining Speed

PANW 110.57
RAS-A 0.00
TEX 28.75
PSA-S 0.00
XOM 81.04

ZIOPHARM Oncology (ZIOP) Reports Palifosfamide Hits PFS Events in Phase 3

ZIOPHARM Oncology, Inc. (Nasdaq: ZIOP) announced today that the Phase 3 (PICASSO 3) trial of palifosfamide (ZIO-201) in first-line metastatic soft tissue sarcoma has reached its target number of progression-free survival (PFS) events. PICASSO 3 is an international, randomized, double-blind, placebo-controlled trial whose primary endpoint is PFS....

Read More




Get Alerted When News Hits On This Stock - FREE!